92 related articles for article (PubMed ID: 16538536)
41. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
[TBL] [Abstract][Full Text] [Related]
42. Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging.
Plevritis SK; Kurian AW; Sigal BM; Daniel BL; Ikeda DM; Stockdale FE; Garber AM
JAMA; 2006 May; 295(20):2374-84. PubMed ID: 16720823
[TBL] [Abstract][Full Text] [Related]
43. Cost-effectiveness analysis of interventions to enhance mammography compliance using computer modeling (CAN*TROL).
Wu JH; Fung MC; Chan W; Lairson DR
Value Health; 2004; 7(2):175-85. PubMed ID: 15164807
[TBL] [Abstract][Full Text] [Related]
44. Coorscreen: a low-cost, on-site mammography screening program.
Greenwood M; Henritze J
Am J Health Promot; 1996; 10(5):364-70. PubMed ID: 10163306
[TBL] [Abstract][Full Text] [Related]
45. Economic burden of breast cancer in northern Serbia.
Milovic M; Tamas T; Crnobrnja V; Paut Kusturica M
Front Public Health; 2023; 11():1265301. PubMed ID: 38162600
[TBL] [Abstract][Full Text] [Related]
46. Single view mammography: a simple and efficent approach to breast cancer screening.
Lundgren B; Jakobsson S
Cancer; 1976 Sep; 38(3):1124-9. PubMed ID: 953959
[TBL] [Abstract][Full Text] [Related]
47. Modelling the future costs of breast screening.
Johnston K
Eur J Cancer; 2001 Sep; 37(14):1752-8. PubMed ID: 11549428
[TBL] [Abstract][Full Text] [Related]
48. Estimating treatment cost functions for progressive diseases: a multiproduct approach with an application to breast cancer.
Butler JR; Furnival CM; Hart RF
J Health Econ; 1995 Aug; 14(3):361-85. PubMed ID: 10145140
[TBL] [Abstract][Full Text] [Related]
49. Mammography screening among women aged 40-49 years shows no benefit.
Hoey J
CMAJ; 2002 Oct; 167(8):898. PubMed ID: 12406951
[No Abstract] [Full Text] [Related]
50. Economic evaluation of diagnostic follow-up after primary treatment for breast cancer. Results of the Working Group on Economic-Organizational Aspects of Follow-up.
Mapelli V; Dirindin N; Grilli R
Ann Oncol; 1995; 6 Suppl 2():61-4. PubMed ID: 8547201
[TBL] [Abstract][Full Text] [Related]
51. The cost of breast cancer recurrences.
Hurley SF; Huggins RM; Snyder RD; Bishop JF
Br J Cancer; 1992 Mar; 65(3):449-55. PubMed ID: 1558803
[TBL] [Abstract][Full Text] [Related]
52. Cost of providing a mobile dental service for dependent older people.
Spatzier H; Stillhart A; Hillebrecht AL; McKenna G; Srinivasan M
Gerodontology; 2021 Dec; 38(4):387-394. PubMed ID: 33470436
[TBL] [Abstract][Full Text] [Related]
53. [Breast cancer screening].
Haehnel P
J Radiol; 2002 Apr; 83(4 Pt 2):517-20. PubMed ID: 12075156
[TBL] [Abstract][Full Text] [Related]
54. Self-medication in Greece: the financial impact from expanding the OTC market.
Naoum V; Nomikos N; Naoum P; Athanasakis K; Kyriopoulos J
Int J Pharm Pract; 2021 Dec; 29(6):541-547. PubMed ID: 34633452
[TBL] [Abstract][Full Text] [Related]
55. Breast cancer costs in New Zealand's public health system.
Lao C; Mondal M; Kuper-Hommel M; Campbell I; Cameron MP; Lawrenson R
N Z Med J; 2021 Nov; 134(1545):36-46. PubMed ID: 34788270
[TBL] [Abstract][Full Text] [Related]
56. Breast cancer screening and dialysis: too much or too little.
Guessous I; Duhn V; McClellan W
Am J Kidney Dis; 2008 Nov; 52(5):830-3. PubMed ID: 18971011
[No Abstract] [Full Text] [Related]
57. Breast cancer: Doubtful health benefit of screening from 40 years of age.
Autier P
Nat Rev Clin Oncol; 2015 Oct; 12(10):570-2. PubMed ID: 26370604
[No Abstract] [Full Text] [Related]
58. Breast Cancer Screening and Health Care Costs.
Heller SL; Moy L
JAMA Intern Med; 2020 Nov; 180(11):1552-1553. PubMed ID: 32776998
[No Abstract] [Full Text] [Related]
59. Breast Cancer Screening and Health Care Costs.
Grimm LJ
JAMA Intern Med; 2020 Nov; 180(11):1552. PubMed ID: 32776997
[No Abstract] [Full Text] [Related]
60. Breast Cancer Screening and Health Care Costs-Reply.
Kunst N; Gross CP
JAMA Intern Med; 2020 Nov; 180(11):1553-1554. PubMed ID: 32777026
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
